Patents
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
12/2004
12/23/2004CA2528012A1 Methods and compositions for controlling efficacy of rna silencing
12/23/2004CA2527582A1 Prodrugs of mitotic kinesin inhibitors
12/23/2004CA2521508A1 Methods for identification of coronaviruses
12/22/2004EP1488335A2 Optimization of crossover points for directed evolution
12/22/2004EP1488236A2 Arrays of microparticles and methods of preparation thereof
12/22/2004EP1487978A2 An improved method for synthesising templated molecules
12/21/2004US6833263 AveC gene product from Streptomyces hygroscopicus
12/16/2004WO2004108904A2 Porcine cmp-n-acetylneuraminic acid hydroxylase gene
12/16/2004WO2004108903A2 Plant transformation and selection
12/16/2004WO2004108902A2 Biocompatible fluorescent silicon nanoparticles
12/16/2004WO2004108901A2 A library of phylogenetically related sequences
12/16/2004WO2004108900A2 Plant transcriptional regulators of disease resistance
12/16/2004WO2004108899A2 Pni microarray and uses
12/16/2004WO2004108898A2 Transfection agents
12/16/2004WO2004108897A2 Sirna libraries
12/16/2004WO2004108896A2 Gene expression profiling of uterine serous papillary carcinomas and ovarian serous papillary tumors
12/16/2004WO2004108894A2 Methods and compositions for amino acid production
12/16/2004WO2004108893A2 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
12/16/2004WO2004108892A2 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, β-AMINOACIDS, α-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS
12/16/2004WO2004108890A2 Dilute methanol -or ethanol- induced production of polypeptides in microorganisms
12/16/2004WO2004108889A2 Hybrid antibodies
12/16/2004WO2004108888A2 Micropositioning cells for tissue engineering
12/16/2004WO2004108887A2 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
12/16/2004WO2004108886A2 Anti-hiv-1 compounds based upon a conserved amino acid sequence shared by gp160 and the human cd4 protein
12/16/2004WO2004108885A2 Fc chimeric proteins with anti-hiv drugs
12/16/2004WO2004108884A2 Composite materials and particles
12/16/2004WO2004108883A2 Transducible dna-binding proteins
12/16/2004WO2004090115A3 Renilla gfp mutants with increased fluorescent intensity and special shift
12/16/2004WO2004081198A3 Methods for modulating angiogenesis with apelin compositions
12/16/2004WO2004081165A3 Novel purified dihydrodipicolinate synthase polypeptides and structures thereof
12/16/2004WO2004078940A3 USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF eIF-5A1
12/16/2004WO2004078911A3 T-cell transformation by recombinant hvs subgroup c
12/16/2004WO2004078905A8 Agents for phytoremediation
12/16/2004WO2004072252A3 Polymerase-based protocols for the introduction of deletions and insertions
12/16/2004WO2004072245A3 Polymerase-based protocols for the introductions of deletions and insertions
12/16/2004WO2004003156A3 Il-21 as a regulator of immunoglobin production
12/16/2004WO2003027254A3 15625 receptor, a novel g-protein coupled receptor
12/16/2004US20040254774 Model for mutually exclusive domain folding molecular switch
12/16/2004US20040253723 Modulation of growth hormone receptor expression and insulin-like growth factor expression
12/16/2004US20040253663 Genes encoding carotenoid compounds
12/16/2004US20040253641 Crystals and structures of ephrin receptor EPHA7
12/16/2004US20040253621 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
12/16/2004US20040253619 Methods for rapid detection and identification of bacterial bioagents
12/16/2004US20040253583 Methods for rapid detection and identification of viral bioagents
12/16/2004CA2528830A1 Transducible dna-binding proteins
12/16/2004CA2528500A1 Porcine cmp-n-acetylneuraminic acid hydroxylase gene
12/16/2004CA2528408A1 Plant transformation and selection
12/16/2004CA2527728A1 Micropositioning cells for tissue engineering
12/16/2004CA2527317A1 A library of phylogenetically related sequences
12/16/2004CA2526365A1 Methods and compositions for amino acid production
12/16/2004CA2525401A1 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
12/15/2004EP1485399A2 METHODS FOR ANALYZING METHYLATED CpG ISLANDS AND GC RICH REGIONS
12/15/2004EP1121448B1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II
12/15/2004CN1555254A 免疫原性脂质体组合物 Immunogenic liposome composition
12/14/2004US6830927 Common neural progenitor for the CNS and PNS
12/09/2004WO2004106497A2 Imageable animal model of sars infection
12/09/2004WO2004106496A2 Methods and compositions for use in homologous recombination in plant cells
12/09/2004WO2004106495A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
12/09/2004WO2004106494A2 A preservative and method for preserving cells
12/09/2004WO2004106493A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
12/09/2004WO2004106491A2 Angiogenin-based hiv-1 therapies
12/09/2004WO2004106490A2 NOVEL METHODS FOR FINDING MUTATIONS CAUSED BY THE INSERTION OF REPETEAD DNAs
12/09/2004WO2004106489A2 Nematode GS-like sequences
12/09/2004WO2004106488A2 Gene expression suppression agents
12/09/2004WO2004106487A2 Improvements in grass endophytes
12/09/2004WO2004061084A8 Modulation of protein functionalities
12/09/2004WO2004050848A3 Methods for antigen masking of red blood cells resulting in reduced hemolysis
12/09/2004WO2004050828A3 Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer
12/09/2004WO2004038003A3 Human polypeptides encoded by polynucleotides and methods of their use
12/09/2004WO2004011612A3 Method of detecting and quantifying hepatitis c virus
12/09/2004US20040250298 Methods for selecting and screening for transformants
12/09/2004US20040249128 Disease detection polypeptides diagnosis, treatment, and prevention of cell proliferative, autoimmune/inflammatory, developmental and neurological disorders
12/09/2004US20040248840 Oligomeric compounds for the modulation of ras expression
12/09/2004US20040248286 Nucleic acid molecules that are differentially regulated in a bipolar disorder and uses thereof
12/09/2004US20040248257 Spleen expressed cell surface protein (SPLEX) for use in treatment and prevention autoimmunity, cancer, transplant rejection and inflammation
12/09/2004US20040248251 Receptors and membrane associated proteins
12/09/2004US20040248189 Method of making a library of phylogenetically related sequences
12/09/2004US20040248174 Small interfering RNA sequences for use in prevention and treatment of vision defects, inflammation, cardiovascular and cell proliferative disorders; RNA interference; gene expression inhibition
12/09/2004CA2527571A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
12/09/2004CA2527296A1 Imageable animal model of sars infection
12/08/2004EP1484412A2 Eukaryotic host cell line in which an endogenous gene has been activated, and uses thereof
12/08/2004EP1484338A1 Methods and compositions for inhibiting neoplastic cell growth
12/08/2004EP1482974A2 Electroporation methods for introducing bioactive agents into cells
12/08/2004EP1482963A2 Controlled modulation of amino acid side chain length of peptide antigens
12/08/2004CN1178955C Modified TNF alpha molecules and DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
12/08/2004CN1178697C Infectious bursits vaccine
12/02/2004WO2004104181A2 Nucleic acid processing methods, kits and devices
12/02/2004WO2004104179A2 Method for isolating and cloning high molecular weight polynucleotide molecules from the environment
12/02/2004WO2004104178A2 Efficient haploid cell sorting for flow cytometer systems
12/02/2004WO2004104177A2 Methods for localizing target molecules in a flowing fluid sample
12/02/2004WO2004104176A2 Method for the identification of inhibitors of ornithine carbamoyltransferase, ketol-acid reductoisomerase, and fungal pathogenicity-conferring gene as antibiotics
12/02/2004WO2004104175A2 Probiotic bacteria and methods
12/02/2004WO2004104171A2 Ranbp2 as modifier of the pten/igf pathway and methods of use
12/02/2004WO2004104170A2 Tools for detecting moraxella catarrhalis.
12/02/2004WO2004104169A2 Identification and use of genes encoding holins and holin-like proteins in plants for the control of microbes and pests
12/02/2004WO2004104168A2 Mrbs as modifiers of the rb pathway and methods of use
12/02/2004WO2004104167A2 A δ-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts
12/02/2004WO2004104166A2 Administration of hyaluronic acid to enhance the function of transplanted stem cells
12/02/2004WO2004104163A2 METHOD OF α-SELECTIVE GLYCOSYLATION
12/02/2004WO2004104162A2 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 100